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Prevention of Subsequent Exercise-Induced Periinfarct Ischemia by
Emergency Coronary Angioplasty in Acute Myocardial Infarction:
Comparison With Intracoronary Streptokinase
ANTHONY Y. FUNG, MD, PETER LAI, MD, JACK E. JUNI, MD,
PATRICK D. V. BOURDILLON, MD, JOSEPH A. WALTON, JR., MD, NATHAN LAUFER, MD,
ANDREW J. BUDA, MD, FACC, BERTRAM PITT, MD, FACC, WILLIAM W. O'NEILL, MD
Ann Arbor, Michigan
To compare the efficacy of emergency percutaneous
transluminal coronary angioplasty and intracoronary
streptokinase in preventing exercise-induced periinfarct
ischemia, 28 patients presenting within 12 hours of the
onset of symptoms of acute myocardial infarction were
prospectively randomized. Of these, 14 patients were
treated with emergency angioplasty and 14 patients re-
ceived intracoronary streptokinase. Recatheterization and
submaximal exercise thallium-201 single photon emis-
sion computed tomography were performed before hos-
pital discharge. Periinfarct ischemia was defined as a
reversible thallium defect adjacent to a fixed defect as-
sessed qualitatively.
Successful reperfusion was achieved in 86% of pa-
tients treated with emergency angioplasty and 86% of
Early coronary reperfusion after acute occlusion has the
potential to salvage myocardium (1-3). Reperfusion can be
achieved by thrombolytic therapy (4-7), emergency bypass
graft surgery (3) or emergency percutaneous transluminal
coronary angioplasty (8-9). After thrombolytic therapy with
streptokinase, however, the majority of patients have sig-
nificant residual coronary lesions (10). After maximal di-
lation by angioplasty, the residual stenosis is usually low
grade (11). Thus, patients treated with streptokinase may
be more likely than those treated with emergency angio-
plasty to develop exercise-induced periinfarct ischemia.
Recently, we reported (11) a clinical trial comparing the
efficacy of emergency angioplasty versus intracoronary
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patients treated with intracoronary streptokinase (p =
NS). Residual stenosis of the infarct-related coronary
artery shown at predischarge angiography was 43.8 ±
31.4% for the angioplasty group and 75.0 ± 15.6% for
the streptokinase group (p < 0.05). Of the angioplasty
group, 9% developed exercise-induced periinfarct isch-
emia compared with 60% of the streptokinase group
(p < 0.05). Thus, patients with acute myocardial in-
farction treated with emergency angioplasty had signif-
icantly less severe residual coronary stenosis and exer-
cise-induced periinfarct ischemia than did those treated
with intracoronary streptokinase. These results suggest
further application of coronary angioplasty in the man-
agement of acute myocardial infarction.
(J Am Coil CardioI1986;8:496-S03)
streptokinase in preserving left ventricular function in the
setting of acute myocardial infarction. The trial was con-
ducted at the University of Michigan Medical Center, Ann
Arbor, and the William Beaumont Hospital, Royal Oak,
Michigan from April 1, 1984 to October 31, 1984. To
evaluate the efficacy of emergency angioplasty in preventing
subsequent exercise-induced periinfarct ischemia, predis-
charge submaximal exercise thallium-20l tomography was
performed in all the patients treated at the University Hos-
pital. The purpose of this study was to compare the incidence
of exercise-induced periinfarct ischemia using predischarge
submaximal exercise thallium-20l single photon emission
computed tomography for the two treatment groups.
Methods
Patient selection. Patients admitted to the University of
Michigan Hospitals from April 1, 1984 to October 31, 1984
with suspected acute myocardial infarction who met the
following inclusion criteria were eligible for randomization
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to treatment with either intracoronary streptokinase or emer-
gency angioplasty. The inclusion criteria were: I) charac-
teristic chest pain of more than 30 minutes' duration, unre-
lieved by nitroglycerin, and arrival at our hospital within
12 hours of symptom onset; 2) electrocardiogram demon-
strating 2 mm or more ST segment elevation or new patho-
logic Q wave, or both, in at least two leads; and 3) informed
consent. The exclusion criteria were I) age over 75 years;
2) contraindication to thrombolytic or anticoagulant therapy;
3) cardiogenic shock, defined as systolic blood pressure of
less than 90 mm Hg with left ventricular end-diastolic pres-
sure of more than 15 mm Hg; 4) previous coronary bypass
grafting; and 5) angiographic exclusion criteria as defined
later. Twenty-eight patients fulfilled the selection criteria
(Table I).
The nature, potential benefits and possible risks of the
study were explained to the patients, who gave written in-
formed consent before angiography. The treatment protocol
was approved by the Human Ethics Committee of our hos-
pital.
Table 1. Summary of Clinical and Angiographic Data of 28
Patients on Study Entry*
PTCA SK
Number of patients 14 14
Age (yr) 55 ± II 55 ± 8
Sex
Male 9 12
Female 5 2
Previous MI I I
Killip class
I II 10
II 2 3
III I I
AMI location
Ant 4 9
Inf 10 5
MI-CA
LAD 4 9
LCx 2 I
RCA 8 4
Severity of MI-CA lesion
Total occlusion 14 12
Subtotal occlusion 0 2
Extent of CAD
One vessel 8 9
Two vessel I 4
Three vessel 5 I
Peak creatine kinase (IUlliter) 3,415 ± 2,544 3,998 ± 2,333t
*There was no significant difference between the angioplasty and strep-
tokinase groups for any of the variables studied.
tn = 13, one patient died early; peak enzyme level not available. AMI
= acute myocardial infarction; Ant = anterior; CAD = coronary artery
disease; Inf = inferior; LAD = left anterior descending coronary artery;
LCx = left circumflex coronary artery; Ml = myocardial infarction; MI-
CA = infarct-related coronary artery; PTCA = percutaneous transluminal
coronary angioplasty; RCA = right coronary artery; SK = intracoronary
streptokinase.
Cardiac catheterization protocol. Potential candidates
for intervention were brought to the cardiac catheterization
laboratory as soon as possible. After the placement of vas-
cular sheaths, heparin, 5,000 U, was administered intra-
venously. Coronary angiography was performed using the
Judkins technique with preformed catheters, beginning with
opacification of the presumed noninvolved coronary artery.
This was followed by left ventriculography. The angio-
graphic exclusion criteria for randomization were: I) 60%
or greater left main coronary artery stenosis; 2) a "left main
equivalent" lesion, defined as 70% or greater stenosis of
both the proximal left anterior descending artery and prox-
imal circumflex artery; and 3) a tortuous distal circumflex
artery occlusion judged to be unsuitable for angioplasty.
Patients who fulfilled all the selection criteria were then
randomized to receive either emergency angioplasty or intra-
coronary streptokinase. Blind randomization was accom-
plished using a closed envelope system. Crossover was not
allowed.
Emergency coronary angioplasty protocol. At the ini-
tiation of angioplasty, low molecular weight dextran, 10%
in 500 ml dextrose solution, was infused intravenously. An
additional 5,000 U heparin was given intravenously. Intra-
venous verapamil, 5 mg, and intracoronary nitroglycerin,
250ug, were given. Angioplasty of the infarct-related coro-
nary artery was performed using a steerable guide wire
system with Griintzig angioplasty catheters. Successful per-
foration of thrombus with the guide wire was followed by
serial balloon inflations to decrease the translesional pres-
sure gradient to less than 20 mm Hg. Repeat selective coro-
nary angiography was then performed. After the interven-
tion procedure, the 14 patients were taken to the coronary
care unit for further medical care. Nifedipine, 30 mg, as-
pirin, 325 mg, and dipyridamole, 75 mg, orally every 8
hours were given. Heparin was infused intravenously to
maintain activated partial thromboplastin time at 2 to 2'12
times control value until repeat angiography was performed
7 to 10 days later.
Intracoronary streptokinase therapy protocol. The 14
patients randomized to receive intracoronary streptokinase
were given the same dose of intravenous verapamil and
intracoronary nitroglycerin as in the angioplasty protocol.
Additional heparin and low molecular weight dextran were
not administered. Streptokinase infusion of 4,000 U/min
was given by ostial infusion. Infusion was continued for 30
minutes after arterial recanalization had occurred or until a
total dose of 300,000 U was administered. Repeat opaci-
fication of the infarct -related coronary artery was performed
every 15 minutes to assess for recanalization. After strep-
tokinase therapy, patients were managed in the coronary
care unit and received the same course of nifedipine, aspirin,
dipyridamole and heparin as in the angioplasty protocol.
Repeat angiography. Patients who survived and re-
mained in stable condition underwent repeat angiography 7
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to 10 days after admission. Standard selective coronary an-
giography was performed. Each stenosis was examined in
multiple projections, including cranial and caudal angula -
tions. The projection in which the stenosis appeared most
severe was selected for analysis. Caliper determination of
percent diameter reduction was obtained. The same method
of measurement was used for the analysis of angiograms
obtained before and after initial therapy was administered .
Lesions of large diagonal or marginal branches were con-
sidered to be lesions of the left anterior descending coronary
artery system or the circumflex coronary artery system, re-
spectively.
Submaximal exercise test with thallium-201 single
photon emission computed tomography. A predischarge
submaximal exercise test with thallium tomography was
performed 7 to 20 days after admission . The test was per-
formed with a motor-driven treadmill 2 or more hours post-
prandially, and medications were not discontinued. Twelve
lead electrocardiograms were recorded at rest and at the end
of each stage. Treadmill exercise was conducted in 3 minute
uninterrupted stages using a constant speed of 2 miles per
hour and a 3% grade increment for each stage. Thallium-
20 I chloride (3 mCi) was injected at peak exercise, and
patients were instructed to continue exercise for an addi-
tional minute. Imaging was then performed immediately and
3 hours later. Each patient exercised to a target heart rate
of 130 beats /min or until angina, marked ST segment
depression, serious ventricular arrhythmia, hypotension or
exhaustion occurred. A test was judged positive when the
patient either experienced chest pain compatible with angina
pectoris or developed diagnostic ischemic electrocardio-
graphic changes (~I mm horizontal or downsloping or ~ 1.5
mm upsloping ST depression).
Imaging was performed using a wide field of view gamma
camera (GE 400AT), with a general all-purpose, parallel
hole collimator. Imaging data were collected over 180° be-
ginning in the right anterior oblique view and ending in the
left posterior oblique view. Sixty-four discrete view images,
that is, one image every 2.8°, were acquired. The image
format was 64 x 64 with 30,000 to 50,000 counts obtained
per image . Each image was acquired for 20 seconds for a
total acquisition time of less than 22 minutes . Transaxial
tomograms were reconstructed by the filtered back projec-
tion method with a ramp-Harming filter. No attenuation
correction was used . Each transaxial tomogram was dis-
played perpendicular to the long axis of the left ventricle.
Each reconstructed slice was 6.25 mm thick. Frontal and
sagittal tomograms were also reconstructed from a series of
transaxial tomograms, corresponding to transverse and lon-
gitudinal sections of the cardiac axis . Postexercise images
were compared with 3 hour delayed images .
Two independent experienced observers interpreted the
images without knowledge of the patient's coronary anat-
omy or the mode of therapy . An image defect was consid-
ered present if there was a discrete region of absent or
decreased activity estimated visually . The defect was ana-
tomically localized as apical, anterior, septal, inferior or
lateral, using all views. A defect present immediately after
exercise and again at 3 hour s delay was considered to in-
dicate a scar, whereas a defect present only immediately
after exercise was considered to reflect ischemia. Either
partial or complete resolution of a defect was considered
evidence of reversible ischemia . If the reversible defect
occurred adjacent to the zone of infarction, it was considered
to represent periinfarct ischemia; if it occurred at a site
removed from the zone of infarction, it was considered to
represent distant ischemia.
Statistical evaluation. Averaged data are presented as
mean ± SD. The Student t, the Pearson's chi-square and
the Fisher exact tests were used for statistical analysis where
appropriate . Differences were considered significant at the
p < 0 .05 level.
Results
Clinical data (Tables 1 and 2). Twenty-one male and
seven female patients fulfilled the study selection criteria.
These patients were randomized so that 14 received intra-
coronary streptokinase and 14 were treated with emergency
coronary angioplasty. The clinical and angiographic data on
study entry are summarized in Table I. The clinical char-
acteri stics for each individual patient studied are presented
in Table 2.
In two patients in the angioplasty group (Patients I and
5) and two patients in the streptokinase group (Patients 17
and 24) reperfusion was not achieved despite interventions.
During hospitalization, one patient (Patient 16) died 4 hours
after receiving intracoronary streptokinase. She developed
severe precordial chest pain in the coronary care unit, and
immediate repeat angiography demonstrated reocclusion of
the left anterior descending coronary artery. She died in the
catheterization laboratory with cardiogenic shock. Two pa-
tients (Patients 18 and 25, both in the streptokinase group)
had emergency coronary bypass graft surgery performed
because of early postinfarct unstable angina. One patient in
the angioplasty group (Patient 3) had silent reocclusion doc-
umented on predischarge angiography .
Twenty-one patients (II angioplasty, IO streptokinase)
consented and completed both repeat angiography and pre-
discharge exercise thallium tomographic studies. Three pa-
tients in the angioplasty group (Patients I , 7 and 14), and
one patient in the streptokinase group (Patient 21) refused
further investigative procedures and only partial data were
available .
Intervention and recatheterization data (Fig. 1, Table
3). The time from symptom onset to successful reperfusion
was 286.7 ± 76.9 minutes for the angioplasty group and
345 .0 ± 92.5 minutes for the streptokinase group (p =
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Table 2. Clinical Characteristicsof 28 Patients
Time to
Age (yr) Prior Killip AMI Extent Reperfusion
Case &Sex MI Class Location MI-CA of CAD (min)
A. Angioplasty Group
I 62M 0 I lnf RCA IV U
2 62M 0 I Inf RCA 3V 130
3 48M 0 I Inf RCA IV 285
4 70F 0 I Inf RCA IV 240
5 40M + I Inf RCA IV U
6 55M 0 I Inf LCx 3V 345
7 34F 0 2 Ant LAD 2V 315
8 55M 0 I Ant LAD 3V 330
9 62F 0 2 Inf RCA IV 21
10 55M 0 3 Ant LAD IV 315
II 64M 0 I Inf RCA 3V 390
12 56F 0 I Inf LCx IV 390
13 37M 0 I Ant LAD IV 225
14 68F 0 I Inf RCA 3V 265
B. Streptokinase Group
15 59M 0 2 Ant LAD IV 195
16 58F 0 I Ant LAD IV 270
17 52M 0 I Ant LAD IV U
18 61M + I Ant LAD 3V 450
19 52M 0 I Inf RCA IV 240
20 39M 0 I Inf RCA IV 450
21 58M 0 I Inf LCx 2V 330
22 41M 0 I Inf RCA IV 480
23 48M 0 I Inf RCA IV 270
24 62M 0 I Ant LAD IV U
25 66F 0 I Ant LAD 2V 330
26 61M 0 2 Ant LAD 2V 315
27 55M 0 2 Ant LAD 2V 390
28 50M 0 3 Ant LAD IV 420
F = female; M = male; U = unsuccessful reperfusion; V = vessel; + = present; 0 = absent; other abbreviations as in Table I.
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Figure I. Severity of stenosis of infarct-related coronary artery
before intervention, immediately after intervention and at recath-
eterization to days after intervention. NS = not significant;PTCA
= percutaneous transluminal coronary angioplasty; STK = intra-
coronary streptokinase.
NS), Initial percent stenosis of the infarct-related coronary
artery was 100% for the angioplasty group and 98.2 ±
5.4% for the streptokinase group (p = NS), Immediately
after intervention, residual stenosis of the infarct-related
coronary artery was 46.4 ± 26,8% for the angioplasty group
and 83,6 ± 15,9% for the streptokinase group (p < 0,01),
At recatheterization 10 days later, the residual stenosis of
the infarct-related coronary artery of the angioplasty group
was significantly less than that of the streptokinase group
(43,8 ± 31.4 versus 75,0 ± 15,6%, P < 0,05), The an-
gioplasty group had a significant increase of global left
ventricular ejection fraction (from 49,6 ± 11,2 to 57,5 ±
13,5%, p < 0.01), but the streptokinase group did not (from
45.5 ± 10.7 to 46.9 ± 12,9%, p = NS),
Submaximal exercise thallium-201 tomographic stud-
ies (Fig. 2, Table 4). Exercise duration and pressure-rate
product achieved were similar for both groups, One (9%)
of the II patients (Patient 12) treated with emergency coro-
nary angioplasty developed exercise-induced periinfarct
ischemia compared with 6 (60%) of the 10 patients treated
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Table 3. Catheterization and Follow-Up Data in 28 Patients
Initial Follow-Up Intervention
MI-CA Postintervention MI-CA Initial Follow-Up ~ Related
Case % Stenosis % Stenosis % Stenosis EF % EF % EF % Collaterals Complications
A. Angioplasty Group
I 100 100 R 56 R NA 0
2 100 40 40 36 55 +19 0
3 100 40 100 53 48 -5 0 Reperfusion VT
4 100 30 30 62 80 + 18 0 AV fistula
5 100 100 100 57 55 -2 +
6 100 20 10 54 72 + 18 0
7 100 40 R 52 R NA + Hematoma; transfused
8 100 60 45 35 45 +10 0 GI bleeding; transfused
9 100 20 10 69 75 +6 0 Reperfusion VF
10 100 40 50 36 35 -I +
II 100 60 60 NA 29 NA + Reperfusion VF
12 100 50 50 54 56 +2 +
13 100 40 20 46 58 +12 0 VF; catheter in LV
14 100 10 10 44 53 +9 +
B. Streptokinase Group
15 100 90 90 24 25 +1 0
16 100 90 NA 55 NA NA 0 Death after 4 hours
17 95 100 50 34 33 -I 0
18 100 95 NA 22 NA NA + Angina, CABG
19 100 80 80 47 49 +2 +
20 100 60 70 58 47 -II +
21 100 95 R 47 R NA 0 Hematoma; transfused
22 80 60 60 53 64 + II 0
23 100 50 50 49 51 +2 0
24 100 100 80 56 51 -5 0
25 100 90 95 55 69 +14 0 Angina, IABP, CABG
26 100 90 90 48 51 +3 0 Reperfusion VF
27 100 80 80 39 38 -I +
28 100 90 70 37 38 +1 0
AV = arteriovenous; CABG = coronary artery bypass graft; EF = ejection fraction; GI = gastrointestinal; IABP = intraaortic balloon pump;
LV = left ventricle; NA = not available; R = refused to participate; VF = ventricular fibrillation; VT = ventricular tachycardia; ~ = difference;
other abbreviations as in Tables I and 2.
with intracoronary streptokinase (p < 0,05), In addition,
all of the seven patients who developed exercise-induced
periinfarct ischemia had 50% or more residual stenosis of
the infarct-related vessel (Fig, 3).
Discussion
Limitations of thrombolytic therapy. Several recent
studies (12-14) have provided evidence that early reper-
fusion by thrombolytic therapy may improve survival after
acute myocardial infarction. However, as emphasized by
Laffel and Braunwald (15), "thrombolytic therapy can at
best only reestablish antegrade flow in the infarct-related
coronary artery, It cannot be expected to reverse factors
responsible for initiation of the thrombus, such as advanced
atherosclerotic plaques, intimal rupture, enhanced platelet
adhesiveness or coronary spasm," Indeed, it is our expe-
rience (II) as well as that of others (16) that after intra-
coronary streptokinase therapy, residual stenosis of the in-
farct-related coronary artery is usually significant and
frequently high grade. These patients are undoubtedly ex-
posed to the risk of rethrombosis and probably further myo-
cardial necrosis. The incidence of in-hospital reocclusion
has been reported to be between 15 and 35% (16-18).
Harrison et al. (19) noted that streptokinase-treated pa-
tients with residual luminal cross-sectional area less than
0.4 rnrrr' had an incidence of rethrombosis of 54%. In con-
trast, patients with less severe residual stenosis did not de-
velop rethrombosis. Gold et al. (20) found that recurrent
in-hospital ischemic events were recorded in 76% of patients
with high grade stenotic lesions of 90% or greater after
streptokinase infusion, whereas ischemic complications in
patients with less severe lesions were substantially less fre-
quent.
Although many of the patients successfully treated with
streptokinase do not develop reocclusion, it is conceivable
lACC Vol. 8. No.3
September 1986:496-503
FUNG ET AL.
ISCHEMIA AFTER REPERFUSION IN ACUTE INFARCTION
501
NS
P<O.O~
Figure 2. Results of predischarge submaximal exercise thallium-
20I tomography. Open columns, percutaneous transluminal coro-
nary angioplasty; hatched columns, intracoronary streptokinase.
NS = not significant.
that a considerable portion of them may develop peri infarct
ischemia during stress. This is illustrated by the results of
this study. Of the 10 patients treated with intracoronary
streptokinase alone, 6 (60%) had exercise-induced peri-
infarct ischemia and the degree of residual stenosis was
75.0 ± 15.6%. Because thrombolytic therapy cannot be
expected to alter the underlying atheromatous lesions and
because it is associated with a significant incidence of sub-
sequent exercise-induced periinfarct ischemia, an alternative
reperfusion strategy may be necessary to reduce this vul-
nerability. In this study, we are able to show that patients
treated with emergency coronary angioplasty had a sub-
stantially lower incidence of exercise-induced peri infarct
ischemia than did patients treated with intracoronary strep-
tokinase. Only 1 (9%) of the II patients in the angioplasty
group had exercise-induced peri infarct reversible defects on
thallium tomography. This observable difference may be
explained by the finding that residual stenosis of the infarct
artery was considerably less severe in the angioplasty group,
being only 43.8 ± 31.4%.
Residual stenosis and exercise-induced periinfarct
ischemia. Our data show that neither of the two patients
with failed reperfusion or reocclusion had exercise-induced
peri infarct ischemia on thallium tomography (Fig. 3). It is
quite possible that in these patients, the infarct progressed
to completion, thus eliminating the development of subse-
quent peri infarct ischemia. Similarly, all six patients with
less than 50% residual stenosis of the infarct-related artery
did not develop such scintigraphic patterns, albeit for pre-
sumably obvious and different reasons. It is not purely co-
incidental that all patients in the latter category were suc-
cessfully treated by coronary angioplasty.
In contrast, 7 (54%) of the remaining 13 patients with
50% or more residual stenosis had exercise-induced re-
versible peri infarct defects on thallium scintigraphy. Some
or all of the following possibilities may be postulated to
explain the lack of thallium defects during exercise in some
patients despite the presence of significant angiographic re-
sidual stenosis. First, periinfarct ischemia may actually be
present but not detected by thallium tomography. This may
be because the ischemic regions are too small or the method
of detection is insufficiently sensitive, or both. Second,
exercise-induced periinfarct ischemic events may in fact be
absent. This may be because of either inadequate exercise
stress relative to the coronary lesion, the presence of ex-
tensive collateral blood flow or the failure of interventional
therapy to salvage myocardium. Regardless of the expla-
nation, the majority of the exercise-induced periinfarct isch-
emic events were observed in the streptokinase group.
Infarct location and time to reperfusion. Although
statistically insignificant, two baseline clinical characteris-
tics appear unevenly in the treated groups, and therefore
deserve further comment. First, a larger proportion of pa-
tients in the angioplasty group had inferior myocardial in-
farction. One (11%) of the nine tested patients in the an-
gioplasty group with inferior infarction developed exercise-
induced periinfarct ischemia whereas four (80%) of the five
patients in the streptokinase group had a similar scinti-
graphic pattern (p < 0.01). In this subgroup, the statistical
significance of the difference between the treated groups is
demonstrated. In contrast, among tested patients with an-
terior infarction, none of the three patients in the angioplasty
group and two (33%) of the six patients in the streptokinase
group had exercise-induced peri infarct ischemia (p = NS).
It may appear that patients with anterior myocardial infarc-
tion are less likely to develop exercise-induced peri infarct
ischemia. However, as mentioned earlier, development of
serious in-hospital ischemic events precluded subsequent
thallium tomographic evaluation in three patients with an-
terior infarction who were treated with streptokinase. Ob-
viously, these three patients developed ischemia even with-
out exercise provocation. Thus, infarct location probably
was not an important factor in the subsequent development
of ischemia.
The second uneven baseline variable is the longer time
interval to reperfusion in the streptokinase-treated group of
patients (Fig. 4). The longer delay could theoretically result
in a bias in the incidence of subsequent exercise-induced
ischemic events against this treatment group. However, the
occurrence of these ischemic events is quite evenly distrib-
uted and appears to be independent of the time intervals to
reperfusion in the streptokinase-treated patients. All 10 tested
patients in the angioplasty group had a time interval to
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Table 4. Submaximal Exercise Test and Thallium Scintigraphy Data in 28 Patients
Exercise Chest ECG Periinfarct Distant
Case Duration PRP Pain STd Scar Ischemia Ischemia
A. Angioplasty Group
8 min 110 0 0 + 0 0
2 7 min 171 + + + 0 +
:I 6 min 149 0 0 + 0 0
4 6 min 196 0 0 + 0 0
5 II min 224 0 0 + 0 0
6 12 min 2 17 0 0 + 0 0
7 Refused
8 9 min 138 0 + + 0 0
9 8 min 199 0 0 + 0 0
10 21 min 2 18 0 0 + 0 0
I I 8 min 177 0 0 + 0 0
12 6 min 30 seconds 312 + + + + 0
13 12 min 30 seconds 272 0 0 + 0 0
14 Refused
B. Streptokinase Group
15 6 min 73 0 0 + + 0
16 Died
17 14 min 23 seconds 224 0 + + 0 0
18 Angina, CABG
19 14 min 190 0 0 + + 0
20 6 min 90 0 0 + + 0
2 1 9 min 224 0 0 + 0 0
22 12 min 290 0 0 + + 0
23 16 min 198 0 0 + + 0
24 15 min 221 0 0 + 0 0
25 Angina, lABP, CABG
26 9 min 247 0 0 + 0 0
27 6 min 50 seconds 200 0 0 + 0 0
28 6 min 122 0 0 + + 0
ECG = electrocardiographic; PRP = pressure-rate product (mm Hg/min x 102) ; other abbreviations as in Tables 2 and 3.
figure 3. Relation between residual stenosis of infarct-related
coronary artery at recatheteri zation and exercise-induced periin-
farct ischemia shown on thallium tomography in II patients who
underwent angioplasty (PTCA) and 10 patients who received strep-
tokinase (STK).
Figure 4. The time from symptom onset to reperfusion is plotted
against the occurrence of exercise-induced periinfarct ischemia in
28 patients. ?TCA = percutaneous transluminal coronary angio-
plasty; SK = intracoronary streptokinase .
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reperfu sion shorter than 400 minute s and only I developed
subsequent exercise-induced peri infarct ischemia . In con-
trast , three of the five tested patients in the streptokinase
group had a similar scintigraphic pattern when the time to
reperfu sion was shorter than 400 minute s (p < 0 .05). Thus,
it may be concluded that the difference in delay in achie ving
reperfusion in the two treatment groups probabl y did not
significantly influence the outcome of our conclusions.
Clinical implications. A delayed redistribution pattern
on thal1 ium scintigraphy signifies, in addition to reversible
ischem ia, the presence of viable myocardial tissue in the
corresponding region (2 1,22) . Gib son et al. (23) showed
that such a scintigraphic pattern seen in pat ients after acute
myocardi al infarction is stron gly predictive of subsequent
clinical cardiac events. In this study, we have shown that
a significant proportion of patients have residual viable myo-
cardium at risk after succe ssful acute interventional therapy .
This is most likely related to the degree of residual stenosis
of the involved coronary artery and is considerably more
prevalent in the patients treated with intracoro nary strep-
tokinase. These findings suggest that after acute myocard ial
infarc tion, patient s treated with intracoronary streptokinase
may be at greater risk than those treated with emergency
coronary angioplasty. Reperfusion by emergency coron ary
angioplasty would therefore appear to be superior to intra-
coronary streptokinase in this respect. Whether angiopl asty
alone or in combination with thromb olytic therap y is su-
perior in salvag ing myocardium and improving long-term
surviva l, must await future studies ,
We gratefully acknowledge the statistical assistance of Carl Dmuchowski
and the secre taria l help of Vi Rhodes in prepar ing this manuscript.
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